Hospice Quality Score Assessment Post Pharmacist Intervention


The study aims to investigate the impact of pharmacist delivered interventions on hospice patients quality metric scores.

Full Title of Study: “Assessing the Impact of Pharmacist Interventions on Hospice Quality Scores”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: April 2023

Detailed Description

The objective of this study is evaluate a program at a hospice involving activities designed to improve the site's National Quality Forum (NQF) and Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores. These scores are calculated by the hospice using existing patient satisfaction survey scores (HCAHPS). The institution quantifies their compliance with national quality metrics (NQF) and reports this existing data to the pharmacist providing counseling services to their patients. The pharmacist assesses for areas for improvement and provides additional counseling services to improve the continuity and quality of care. The pilot program is scheduled to launch April 2020 and the researchers will look to assess for changes in the NQF scores, HCAHPS scores, and time for their partnering pharmacy to refill the first set of prescriptions.


  • Other: Medication safety review
    • Implementation of a medication safety review using a clinical decision support system

Arms, Groups and Cohorts

  • Intervention
    • Patients that receive pharmacist-delivered services in the pilot program
  • Control
    • Patients that do not receive pharmacist-delivered services in the pilot program

Clinical Trial Outcome Measures

Primary Measures

  • National Quality Forum Score
    • Time Frame: 6 months
    • Performance metric used by hospice. Scale 0 – 100 (0=min; 100-high)
  • Consumer Assessment of Healthcare Providers and Systems
    • Time Frame: 6 months
    • Performance metric used by hospice (0=min; 100-high)
  • Time to refill
    • Time Frame: 6 months
    • Time to refill prescription from hospice organization (0=min; 100-high)

Participating in This Clinical Trial

Inclusion Criteria

Adult patients who were referred to hospice by a healthcare provider

Exclusion Criteria

Patients 89 years or older

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 88 Years

Investigator Details

  • Lead Sponsor
    • Tabula Rasa HealthCare
  • Provider of Information About this Clinical Study
    • Principal Investigator: Jenny Bingham, Director, Ambulatory Care Residency Programs & Research – Tabula Rasa HealthCare
  • Overall Official(s)
    • Jennifer Bingham, PharmD, Principal Investigator, Tabula Rasa HealthCare

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.